This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2016, a number of states filed what eventually became the first in a trio of lawsuits against many of the largest generic companies for allegedly coordinating efforts to fix and maintain prices for dozens of medications to treat a variety of ailments.
This milestone marks a key development in BBL’s support for diabetes care and insulin accessibility in Malaysia. Since its entry into the Malaysian market in 2016, Biocon Biologics has supported more than 345,000 diabetes patients through the supply of rh-insulin. Biocon Biologics collaborates with Duopharma Marketing Sdn.
Updated February 26, 2016. The goal over the next 5 years is to shift from animal testing being a requirement to being an exception. 3,6 REFERENCES FDA drug approval process infographic (horizontal). Accessed June 19, 2025. link] Consolidated Appropriations Act of 2023, HR 2617, 117th Cong (2023). Accessed June 23, 2025.
The 2016 World Health Organization classification of MCL recognizes 2 molecular subtypes that reflect divergent pathogenesis and clinical behavior 2 : Classical MCL is derived from naive B cells that lack somatic hypermutation in IGHV , do not transit through the germinal center, and express the SOX11 transcription factor.
One study conducted in 2016-2017 found that 10% of new prescriptions for contraceptive pills and patches were written by pharmacists during that period. 1 Meredith also cited promising outcomes from states like Oregon.
For example: Diabetes According to the Centers for Medicare and Medicaid Services , among Asian Americans, the diagnosed diabetes rate is 9.2%; this varies significantly by subgroupas high as 12.2% However, AANHPI subgroups face unique health challenges that underscore the importance of disaggregated data in health care. for Samoans.
FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo. July 8, 2025. Nasrallah, H. Bossie, C. Hough, D., & & Turkoz, I. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy.
1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).
Ross et al published a landmark study in 2016 evaluating psilocybin’s impact on anxiety and depression in 51 patients with life-threatening cancer. It triggered an outflow of new psychedelic research interest and added evidence to the relationship between mystical experience and the efficacy of psilocybin.
SHOW MORE The study found biosimilar initiation rose to nearly 42% from 2016 to 2023. 1 For this retrospective cohort study, the investigators collected data from January 1, 2016, to December 31, 2023, to assess the uptake of biosimilars within the pediatric IBD space. One patient started Inflectra in 2016 and 2017.
Biggest spenders DTC ads are almost exclusively leveraged for brand name drugs, with two-thirds of that spending concentrated on just 39 drugs between 2016 and 2018, according to a Government Accountability Office report. Some of the biggest spenders are shelling out millions to get their brands in front of American audiences.
On December 13, 2024, Lupin, a global pharmaceutical company, announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH. The move is aimed at strengthening Lupins diabetes portfolio in India. In addition, 25 million people are pre-diabetic.
031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%
1 Scientific evidence between January 1, 2016, and January 31, 2023, was included in the study. This was assessed by analyzing real-world pharmacoepidemiological data and conducting a systematic review and meta-analysis to further quantify this risk.
link] [9] Pew Charitable Trusts, How to Improve Electronic Health Record Usability and Patient Safety (fact sheet, August 2016), [link] [10] Mohsen and Aziz, “The Blue Button Project,” 1d. [11] Junaid et al., Recent Advancements in Emerging Technologies for Healthcare Management Systems: A Survey,” Healthcare 10, no. 10 (2022): 1940.
Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. August 22, 2016. Pediatr Res. 2023;93(4):1096-1104. doi:10.1038/s41390-022-02188-4; 1. Livanos AE, Greiner TU, Vangay P, et al. Nature News. Accessed May 8, 2025. link] Staller K, Oln O, Sderling J, et al.
based RWJBarnabas Health, in 2016 as COO and became CEO in 2018. Since becoming CEO of Bristol Health in 2016, Mr. Barwis has driven transformation centered on patient satisfaction, operational excellence and health equity. Mr. Johnson was named president and CEO of LMH Health in 2016. Patrick Ahearn. Kurt Barwis. Steven Edgar.
billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023. billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023.
She was appointed vice president and chief experience officer of the system in May 2016. Pankow has overseen vaccine governance, led the expansion of team-based care, helmed the HonorHealth medical group social determinants of health initiative, and implemented a diabetes prevention program. Alan Dubovsky. Shannon Patterson.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content